AGP Picks
View all

SPS and Tandem Health team up on ambient AI for European care

6 hours ago
SPS and Tandem Health team up on ambient AI for European care

Speech Processing Solutions and Tandem Health have launched a partnership to help European healthcare providers adopt ambient AI documentation at scale. The companies are pairing Philips SpeechMike Ambient wearable audio capture with Tandem’s AI Medical Assistant and will showcase the co-branded solution at HLTH Europe 2026 in Amsterdam.

Why it matters: - Healthcare systems across Europe are adopting ambient AI to cut administrative work and improve clinical workflows. - Speech capture quality can make or break clinical documentation, so the microphone layer matters as much as the software. - The partnership is designed to make ambient AI easier to deploy across different care settings without forcing clinicians into new workflows.

What happened: - Speech Processing Solutions (SPS) and Tandem Health announced a partnership to accelerate ambient AI adoption across European healthcare. - The companies combined the Philips SpeechMike Ambient Wearable AI Assistant microphone with Tandem’s AI Medical Assistant. - The combined workflow is meant to capture conversations from the first word and turn them into structured clinical documentation. - SPS is a global leader in professional dictation and AI-powered speech solutions sold under the Philips brand. - Tandem Health describes itself as one of Europe’s fastest-growing AI companies for healthcare.

The details: - SPS said it has spent more than 70 years building professional speech technology for demanding clinical environments. - SPS and Tandem want the solution to support more natural and efficient clinical documentation across European healthcare. - Tandem said ambient AI can reduce administrative burden for clinicians, but documentation quality depends on high-quality audio capture. - The companies plan to present the co-branded SpeechMike Ambient at Tandem Health’s booth at HLTH Europe 2026 in Amsterdam. - HLTH Europe 2026 runs June 15-18 at booth D70. - Visitors at HLTH Europe will be able to see the Philips speech capture technology and Tandem’s AI Medical Assistant working in a single clinician-friendly workflow. - SPS is active in 50+ countries and says it has more than 4 million users and a worldwide network of 1,000+ partners. - SPS develops dictation and transcription tools, AI-powered speech recognition, and dictation devices sold under the Philips brand. - SPS is headquartered in Vienna, Austria, with regional offices in Australia, Canada, Belgium, France, Germany, the United Kingdom and the United States. - Tandem Health’s AI Medical Assistant supports clinicians across the full patient visit, from preparation and documentation to coding and follow-up. - Tandem says its AI Medical Scribe and Coding Assistant are CE marked under EU MDR at Class IIa. - Tandem integrates with more than 100 medical record systems across Europe and says it is used by more than 5,000 care organisations. - Tandem’s website is Tandem Health. - SPS lists SpeechLive and Philips Dictation as company websites.

Between the lines: - The partnership signals a push to position ambient AI as a workflow upgrade, not just a software add-on. - Pairing hardware-grade speech capture with AI documentation could help address a common blocker in clinical AI deployments: poor input quality. - Showcasing the system at a major healthcare conference suggests both companies want to use the event to validate the product with buyers and clinical leaders.

What’s next: - SPS and Tandem will demo the co-branded solution at HLTH Europe 2026 in Amsterdam. - The broader test will be whether the combined product can help providers deploy ambient AI more reliably at scale across European healthcare settings. - If adoption grows, the partnership could become a model for tying trusted capture hardware to clinical AI software.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

The European Current

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Sign up for:

The European Current

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.